Abstract
Background
With respect to deficient donor grafts and the risk of tumour recurrence, indication for orthotopic liver transplantation (OLT) is still controversial. OLT offers the only chance for both the tumour and the underlying liver disease to be eliminated in patients with hepatocellular carcinoma (HCC) and cirrhosis. The aim of this study was to assess survival and related factors of recurrence.
Patients and methods
This retrospective study analyses data from 45 patients with HCC (UICC stage I/II, n=16; III, n=13; IV, n=12) treated with OLT between 1992 and 2002 in our centre. There were 39 primary tumours and two recurrent ones after previous surgical resection. Four perioperative deaths were excluded from analysis.
Results
Mean follow-up was 50.4 months. Five-year rates after OLT were 64% for overall survival, 78% for disease-specific survival, 73% for recurrence-free survival, and 22% for tumour recurrence. No tumour recurrence has been observed so far in patients with tumours of UICC stage I/II. None of the patient characteristics had a significant impact on survival, while tumour stage was significantly correlated with freedom from recurrence.
Conclusion
Our results demonstrate that the risk of recurrent HCC in liver transplanted patients is low for small and solitary tumours with no vascular invasion (UICC I/II). Even in advanced tumour stages (UICC III/IV), there is a real chance of cure or at least a survival benefit in selected patients.
Similar content being viewed by others
References
Ganne-Carrie N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Deny P, Trinchet JC, Callard P, Guettier C, Beaugrand M (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 23:1112–1118
Lange JF, Leese T, Castaing D, Bismuth H (1989) Repeated hepatectomy for recurrent malignant tumors of the livers. Surg Gynecol Obstet 169:119–126
Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M (1994) Transcatheter oily chemoembolisation for hepatocellular carcinoma. Cancer 74:16–24
Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A (1998) Treatment of unresectable hepatocellular carcinoma with Lipiodol chemoembolization: a multicentre randomised trial. Group CHC. J Hepatol 29:129–134
Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 197:101–108
Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H (1997) Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 225:39–48
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P (2000) Radiofrequency ablation of hepatocellular carcinoma in 110 patients with cirrhosis. Ann Surg 232:381–391
O’Grady LG, Polson RJ, Rolles K, Calne RY, Williams R (1988) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207:373–379
Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I (2002). Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 26:257–263
Mazzafero V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozetti F, Montalto F, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699
Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, Fabregat J, Casanovas T, Torras J, Baliellas C, Ibanez L, Moreno P, Casais L (1997) Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25:1485–1489
Yao FY, Ferrel L, Bas NM, Watson JJ, Bachetti P, Venook A, Ascher N, Robert JP (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits but does not adversely impact on survival. Hepatology 33:1394–1403
Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229:790–800
Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, Lacy AM, Gonzalez X, Vilana R, Bru C, Sole M, Visa J (1996) Hepatocellular carcinoma and cirrhosis—results of surgical treatment in a European series. Ann Surg 223:297–302
Molmenti EP, Klintmalm GB (2000) Cancer and liver transplantation Immunol Rev 14:183–198
Herold C, Reck T, Fischler P, Ott R, Radespiel-Troeger M, Ganslmayer M, Hohenberger W, Hahn EG, Schuppan D (2002) Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European center. Liver 22:23–28
Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, Starzl TE (2000) Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 191:389–394
Yao FY, Ferrell L, Bass NM, Bachetti P, Ascher NL, Roberts JP (2002) Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 8:765–774
Llovet JM, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Bru C, Navasa M, Ayuso MDC, Sole M, Real MI, Villana R, Rimola A, Visa J, Rodes J (1998) Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 27:1572–1577
Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S (2000) Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 88:538–543
Farmer DG, Rosove MH, Shaked A, Busuttil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219:236–247
Molmenti EP, Klintmalm GB (2002) Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 8:736–748
Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma. A report of impact of tumor characteristics on outcome. Ann Surg 228; 479–490
De Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D (2003) Liver transplantation for hepatocellular carcinoma: should the current criteria be changed? Transpl Int 16:115–122
Llovet JM, Fuster J, Bruix J for the Barcelona Clinic Liver Cancer (BCLC) Group (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–1440
Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8:873–883
Malago M, Testa G, Frilling A, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Treichel U, Cicinnati V, Gerken G, Broelsch CE (2003) Right living donor liver transplantation: an option for adult patients—a single institution experience with 74 patients. Ann Surg 238:853–863
Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K (2003) Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75 [Suppl]: S37–S40
Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A (2001) Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 33:1073–1079
Millis JM, Cronin DC, Brady LM, Newell KA, Woodle ES, Bruce DS, Thistlethwaite JR, Broelsch CE (2000) Primary living-donor liver transplantation at the University of Chicago—technical aspects of the first 104 recipients. Ann Surg 232:104–111
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented at the workshop on malignant tumours in organ transplantation, Department of Surgery, Ludwig Maximillians University, Munich, 4–5 April 2003
Rights and permissions
About this article
Cite this article
Yedibela, S., Förtsch, T., Hohenberger, W. et al. Liver transplantation for hepatocellular carcinoma: a single European centre experience. Langenbecks Arch Surg 389, 104–109 (2004). https://doi.org/10.1007/s00423-003-0456-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-003-0456-5